Skip to main content

BBS Research

Research Areas

Our faculty and students participate in a wide range of broad research areas, including:

Research Funding

Our division received external awards in the amount of $11.5 million in 2016, which represents 50 percent of the Sanford School of Medicine's grant and contract income. About 55 percent of our 40 faculty members are actively engaged in scholarly and research activities.

Student Opportunities

We offer the following programs for students:

  • Physician Scientist Program
  • Summer Program for Undergraduate Research in Addiction
  • Medical Student Summer Research Program
  • Biomedical Research Infrastructure Network

View Research Opportunities

Research Locations

Along with our labs at Lee Medical Building in Vermillion, we also conduct research at two other labs in South Dakota:

Sanford ResearchSanford Research

Sanford Research is a non-profit research institute in Sioux Falls, South Dakota. A component of Sanford Health, a large regional healthcare organization, Sanford Research has state-of-the-art facilities, a collaborative research environment and a dedication to student training. Several areas of cutting-edge research are affiliated with the USD Basic Biomedical Sciences program, including pediatrics and rare disease, cancer biology and immunotherapy, diabetes, cellular therapies and stem cell biology, genetics and genomics, enabling technologies and environmental influences on health and disease.

Learn More

Avera Institute for Human GeneticsAvera Institute for Human Genetics

The Avera Institute for Human Genetics (AIHG) is affiliated with Avera McKennan Hospital & University Health Center in Sioux Falls, South Dakota. Avera McKennan is a nationally recognized hospital and has been ranked in the top 5 percent of the nation's 4,500 hospitals for clinical excellence by Healthgrades. The AIHG was created in 2006 and has research initiatives in pharmacogenetics and twin studies of complex diseases and phenotypes. Cancer genetics is also a focus of the AIHG and experiments are conducted using next-generation sequencing technologies to investigate mutations driving tumor growth and disease.

Learn More